|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
Netherlands Trial Register |
|
Last refreshed on:
|
28 April 2013 |
|
Main ID: |
NTR956 |
|
Date of registration:
|
15/04/2007 |
|
Primary sponsor: |
|
|
Public title:
|
NT-proBNP Testing in Patients Presenting to the Emergency Department With Acute Dyspnea: Evaluation of Effects on Treatment, Hospitalisation Rate and Costs
|
|
Scientific title:
|
NT-proBNP in Acute Dyspnea: Effects on Treatment, Hospitalisation and Costs -
|
|
Date of first enrolment:
|
12/1/2004 |
|
Target sample size:
|
477 |
|
Recruitment status: |
complete |
|
URL:
|
http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=956 |
|
Study type:
|
intervention |
|
Study design:
|
Randomised: Yes; Masking: Single; Control: Not applicable; Group: Parallel; Type: -
|
|
|
Countries of recruitment
|
|
The Netherlands
| | | | | | | |
|
Contacts
|
|
Name:
|
A.H.
Meiracker, van den |
|
Address:
|
Erasmus MC, 's Gravendijkwal 230
3015 CE
Rotterdam
The Netherlands |
|
Telephone:
|
+31-10-4639222 |
|
Email:
|
a.vandenmeiracker@erasmusmc.nl |
|
Affiliation:
|
|
|
|
Name:
|
J.H.W.
Rutten |
|
Address:
|
Erasmus MC, 's Gravendijkwal 230
3015 CE
Rotterdam
The Netherlands |
|
Telephone:
|
+31 10-4639222 |
|
Email:
|
j.rutten@erasmusmc.nl |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Age 18 years or older;
2. Acute dyspnea as the most prominent complaint
Exclusion criteria: 1. Acute dyspnea due to a trauma;
2. Acute dyspnea due to cardiogenic shock;
3. Renal failure requiring dialysis.
Age minimum:
Age maximum:
Gender:
|
|
Health Condition(s) or Problem(s) studied
|
B-type natriuretic peptide , Dyspnea , Costs, Cost-effectiveness
|
|
Intervention(s)
|
Study-group: Measurement of NT-proBNP plasma level at presentation in the Emergency Department.
Control-group: No measurement of NT-proBNP plasma level at presentation in the Emergency Department. Blood was collected for determination of NT-proBNP levels at the end of the study.
|
|
Primary Outcome(s)
|
1. Time to discharge;
2. Cost of treatment
|
|
Secondary Outcome(s)
|
1. Duration of stay at the ED;
2. Proportion of patients admitted to the hospital;
3. Proportion of patients admitted to an intensive or coronary care unit;
4. Specialist consultations;
5. Medical treatment;
6. Diagnostic investigations
|
|
Secondary ID(s)
|
|
ISRCTN28653133
|
|
Source(s) of Monetary Support
|
|
Mrace Comittee, Erasmus MC
|
|